BridgeBio Pharma · Field Based - Germany
BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.
BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth.
At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.
To learn more about our story and company culture, visit us at https://bridgebio.com
You will report to the Senior Medical Director, Europe Central Region, and work closely with fellow Medical Science Liaisons, local Market Access, and regional and global Medical Affairs teams. Together, you will execute the Medical Affairs brand plan and strategic initiatives that support BridgeBio’s mission to deliver transformative medicines for patients with genetic diseases and genetically driven cancers.
Your primary purpose will be to build our KOL and HCP base in the pre-launch and launch phase, as BridgeBio engages with most customers in Germany for the first time. You will work on our initiatives during early pre-launch through post-launch, ensure medical and scientific education of HCPs as part of our launch efforts, engage with HCPs to increase diagnosis rates and support market access related work as a key stakeholder.
This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in medical and scientific engagement in the context of introducing a biotech company for the first time to KOLs, medical and scientific engagement and making a remarkable contribution to a disease space in pre-launch and launch phase in a rare disease and orphan condition. We look for strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.
The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required of job incumbents. Therefore, job incumbents are expected to perform all other duties as assigned or required, as training and experience allow.
This is a Germany-based, field-facing role with a strong customer engagement component. The position requires travel throughout Germany, as well as periodic travel across Europe for conferences, KOL meetings, and speaker programs. Local team meetings and designated office location in Germany is Munich.
We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn , X , Facebook , Instagram , YouTube , and TikTok .
Jobb.ai is an independent skill benchmarking platform. Applications are submitted on the employer's official website.